Although the FGF family of paracrine factors has a broad range of functions, major findings support the idea that they primarily stimulate proliferation and differentiation. To fulfill many diverse functions, FGFs can be alternatively spliced or even have different initiation codons to create hundreds of different FGF
isoforms. One of the most important functions of the FGF receptors (FGFR) is in limb development. This signaling involves nine different
alternatively spliced isoforms of the receptor.
Fgf8 and
Fgf10 are two of the critical players in limb development. In the forelimb initiation and limb growth in mice, axial (lengthwise) cues from the intermediate
mesoderm produces
Tbx5, which subsequently signals to the same
mesoderm to produce
Fgf10.
Fgf10 then signals to the
ectoderm to begin production of
Fgf8, which also stimulates the production of
Fgf10. Deletion of
Fgf10 results in limbless mice. Additionally, paracrine signaling of Fgf is essential in the developing eye of chicks. The
fgf8
mRNA becomes localized in what differentiates into the neural
retina of the
optic cup. These cells are in contact with the outer ectoderm cells, which will eventually become the lens. Binding of FGF to FGFR
phosphorylates the idle
kinase and activates the RTK pathway. This pathway begins at the cell membrane surface, where a
ligand binds to its specific receptor. Ligands that bind to RTKs include
fibroblast growth factors, epidermal growth factors, platelet-derived growth factors, and
stem cell factor. An
adaptor protein (such as SOS) recognizes the phosphorylated tyrosine on the receptor. This protein functions as a bridge which connects the RTK to an intermediate protein (such as GNRP), starting the intracellular signaling cascade. In turn, the intermediate protein stimulates GDP-bound Ras to the activated GTP-bound Ras. GAP eventually returns Ras to its inactive state. Activation of
Ras has the potential to initiate three signaling pathways downstream of Ras: Ras→Raf→MAP kinase pathway, PI3 kinase pathway, and Ral pathway. Each pathway leads to the activation of transcription factors which enter the nucleus to alter gene expression. article for details.
RTK receptor and cancer Paracrine signaling of growth factors between nearby cells has been shown to exacerbate
carcinogenesis. In fact, mutant forms of a single RTK may play a causal role in very different types of cancer. The Kit
proto-oncogene encodes a tyrosine kinase receptor whose ligand is a paracrine protein called stem cell factor (SCF), which is important in
hematopoiesis (formation of cells in blood). The Kit receptor and related tyrosine kinase receptors actually are inhibitory and effectively suppresses receptor firing. Mutant forms of the Kit receptor, which fire constitutively in a ligand-independent fashion, are found in a diverse array of cancerous malignancies.
RTK pathway and cancer Research on
thyroid cancer has elucidated the theory that paracrine signaling may aid in creating tumor microenvironments.
Chemokine transcription is upregulated when Ras is in the GTP-bound state. The chemokines are then released from the cell, free to bind to another nearby cell. Paracrine signaling between neighboring cells creates this positive feedback loop. Thus, the constitutive transcription of upregulated proteins form ideal environments for tumors to arise. Effectively, multiple bindings of ligands to the RTK receptors overstimulates the Ras-Raf-MAPK pathway, which
overexpresses the
mitogenic and invasive capacity of cells.
JAK-STAT pathway In addition to RTK pathway,
fibroblast growth factors can also activate the
JAK-STAT signaling pathway. Instead of carrying covalently associated tyrosine kinase domains, Jak-STAT receptors form noncovalent complexes with tyrosine kinases of the Jak (
Janus kinase) class. These receptors bind are for
erythropoietin (important for
erythropoiesis),
thrombopoietin (important for
platelet formation), and
interferon (important for mediating immune cell function). After dimerization of the cytokine receptors following ligand binding, the JAKs transphosphorylate each other. The resulting phosphotyrosines attract STAT proteins. The STAT proteins dimerize and enter the nucleus to act as
transcription factors to alter gene expression. Phenotype and survival of mice after knockout of some JAK or STAT genes:
Aberrant JAK-STAT pathway and bone mutations The JAK-STAT signaling pathway is instrumental in the development of limbs, specifically in its ability to regulate bone growth through paracrine signaling of cytokines. However, mutations in this pathway have been implicated in severe forms of dwarfism:
thanatophoric dysplasia (lethal) and
achondroplasic dwarfism (viable). This is due to a mutation in a
Fgf gene, causing a premature and
constitutive activation of the
Stat1 transcription factor.
Chondrocyte cell division is prematurely terminated, resulting in lethal dwarfism. Rib and limb bone growth plate cells are not transcribed. Thus, the inability of the rib cage to expand prevents the newborn's breathing.
JAK-STAT pathway and cancer Research on paracrine signaling through the JAK-STAT pathway revealed its potential in activating invasive behavior of ovarian
epithelial cells. This epithelial to
mesenchymal transition is highly evident in
metastasis. Paracrine signaling through the JAK-STAT pathway is necessary in the transition from stationary epithelial cells to mobile mesenchymal cells, which are capable of invading surrounding tissue. Only the JAK-STAT pathway has been found to induce migratory cells. == Hedgehog family ==